Renate S. Hagedoorn

2.5k total citations
48 papers, 1.8k citations indexed

About

Renate S. Hagedoorn is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Renate S. Hagedoorn has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 35 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Renate S. Hagedoorn's work include CAR-T cell therapy research (38 papers), Immune Cell Function and Interaction (21 papers) and Immunotherapy and Immune Responses (18 papers). Renate S. Hagedoorn is often cited by papers focused on CAR-T cell therapy research (38 papers), Immune Cell Function and Interaction (21 papers) and Immunotherapy and Immune Responses (18 papers). Renate S. Hagedoorn collaborates with scholars based in Netherlands, United States and United Kingdom. Renate S. Hagedoorn's co-authors include Mirjam H.M. Heemskerk, J.H. Frederik Falkenburg, Michel G.D. Kester, Marleen M. van Loenen, Roel Willemze, Avital L. Amir, Renate de Boer, Manja Hoogeboom, Dirk M. van der Steen and Menno A. W. G. van der Hoorn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Renate S. Hagedoorn

48 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renate S. Hagedoorn Netherlands 21 1.2k 1.2k 458 451 215 48 1.8k
Patrick P.C. Boor Netherlands 26 1.1k 1.0× 1.0k 0.9× 334 0.7× 181 0.4× 91 0.4× 47 2.1k
Chiara F. Magnani Italy 16 1.4k 1.2× 935 0.8× 435 0.9× 356 0.8× 198 0.9× 39 2.1k
Inge Jedema Netherlands 24 998 0.8× 776 0.7× 421 0.9× 247 0.5× 657 3.1× 79 1.8k
Tatiana N. Golovina United States 18 1.3k 1.1× 604 0.5× 445 1.0× 174 0.4× 215 1.0× 21 1.8k
Tessa Kerre Belgium 26 940 0.8× 769 0.7× 670 1.5× 214 0.5× 427 2.0× 112 2.1k
Renate de Boer Netherlands 16 654 0.6× 576 0.5× 187 0.4× 199 0.4× 114 0.5× 30 1.1k
Henri Vié France 29 1.7k 1.4× 733 0.6× 241 0.5× 180 0.4× 213 1.0× 71 2.3k
Michelle A. Hurchla United States 16 1.3k 1.1× 784 0.7× 408 0.9× 149 0.3× 166 0.8× 24 2.0k
Armin Ghobadi United States 20 460 0.4× 1.6k 1.4× 493 1.1× 385 0.9× 328 1.5× 152 2.0k
Béatrice Clemenceau France 21 590 0.5× 449 0.4× 233 0.5× 185 0.4× 125 0.6× 50 1.2k

Countries citing papers authored by Renate S. Hagedoorn

Since Specialization
Citations

This map shows the geographic impact of Renate S. Hagedoorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate S. Hagedoorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate S. Hagedoorn more than expected).

Fields of papers citing papers by Renate S. Hagedoorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renate S. Hagedoorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate S. Hagedoorn. The network helps show where Renate S. Hagedoorn may publish in the future.

Co-authorship network of co-authors of Renate S. Hagedoorn

This figure shows the co-authorship network connecting the top 25 collaborators of Renate S. Hagedoorn. A scholar is included among the top collaborators of Renate S. Hagedoorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renate S. Hagedoorn. Renate S. Hagedoorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Remst, Dennis F.G., et al.. (2025). CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells. Molecular Therapy. 33(4). 1642–1658. 2 indexed citations
2.
Wouters, Anne K., Renate S. Hagedoorn, Michel G.D. Kester, et al.. (2023). Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain. Journal of Hematology & Oncology. 16(1). 16–16. 9 indexed citations
3.
Hagedoorn, Renate S., et al.. (2023). Chimeric HLA antibody receptor T cells to target HLA‐specific B cells in solid organ transplantation. HLA. 102(4). 436–448. 4 indexed citations
4.
Wouters, Anne K., Marian van de Meent, Dennis F.G. Remst, et al.. (2023). PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer. Frontiers in Immunology. 14. 1121973–1121973. 16 indexed citations
5.
Remst, Dennis F.G., et al.. (2023). Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma. Blood Advances. 7(20). 6178–6183. 13 indexed citations
6.
Remst, Dennis F.G., Michel G.D. Kester, Renate S. Hagedoorn, et al.. (2023). Antibody-mediated delivery of viral epitopes to redirect EBV-specific CD8+ T-cell immunity towards cancer cells. Cancer Gene Therapy. 31(1). 58–68. 4 indexed citations
7.
Morton, Laura T., Umesh Chaudhari, Dennis F.G. Remst, et al.. (2023). Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential. Molecular Therapy — Methods & Clinical Development. 28. 249–261. 7 indexed citations
8.
Wouters, Anne K., Renate S. Hagedoorn, Michel G.D. Kester, et al.. (2022). Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01–Restricted 20mer Epitope. The Journal of Immunology. 208(8). 1851–1856. 3 indexed citations
9.
Hagedoorn, Renate S., Michel G.D. Kester, Anne K. Wouters, et al.. (2022). SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells. eLife. 11. 15 indexed citations
10.
Hagedoorn, Renate S., Dennis F.G. Remst, Dirk M. van der Steen, et al.. (2022). WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma. Journal for ImmunoTherapy of Cancer. 10(6). e004409–e004409. 17 indexed citations
11.
Wouters, Anne K., Lorenz Jahn, Renate S. Hagedoorn, et al.. (2021). A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy. Molecular Therapy. 30(2). 564–578. 9 indexed citations
12.
Orlando, Domenico, Evelina Miele, Biagio De Angelis, et al.. (2018). Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma. Cancer Research. 78(12). 3337–3349. 56 indexed citations
13.
Hagedoorn, Renate S., Michel G.D. Kester, Dirk M. van der Steen, et al.. (2017). Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia. Blood. 130. 168–168. 1 indexed citations
14.
Gezgin, Gülçin, Jinfeng Cao, Mehmet Doğrusöz, et al.. (2017). PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma. JAMA Ophthalmology. 135(6). 541–541. 86 indexed citations
15.
Amir, Avital L., Dirk M. van der Steen, Marleen M. van Loenen, et al.. (2011). PRAME-Specific Allo-HLA–Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer. Clinical Cancer Research. 17(17). 5615–5625. 92 indexed citations
16.
Melenhorst, J. Joseph, Marian van de Meent, Michel G.D. Kester, et al.. (2011). Allogeneic HLA-A*02–Restricted WT1-Specific T Cells from Mismatched Donors Are Highly Reactive but Show Off-Target Promiscuity. The Journal of Immunology. 187(5). 2824–2833. 28 indexed citations
17.
Amir, Avital L., Lloyd D’Orsogna, Dave L. Roelen, et al.. (2010). Allo-HLA reactivity of virus-specific memory T cells is common. Blood. 115(15). 3146–3157. 231 indexed citations
18.
Loenen, Marleen M. van, Renate de Boer, Avital L. Amir, et al.. (2010). Mixed T cell receptor dimers harbor potentially harmful neoreactivity. Proceedings of the National Academy of Sciences. 107(24). 10972–10977. 180 indexed citations
19.
Veken, Lars T. van der, María Díez‐Campelo, Menno A. W. G. van der Hoorn, et al.. (2009). Functional Analysis of Killer Ig-Like Receptor-Expressing Cytomegalovirus-Specific CD8+ T Cells. The Journal of Immunology. 182(1). 92–101. 40 indexed citations
20.
Heemskerk, Mirjam H.M., Manja Hoogeboom, Renate S. Hagedoorn, et al.. (2004). Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer. The Journal of Experimental Medicine. 199(7). 885–894. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick P.C. Boor Breakdown of academic impact, for papers by Chiara F. Magnani Breakdown of academic impact, for papers by Inge Jedema Breakdown of academic impact, for papers by Tatiana N. Golovina Breakdown of academic impact, for papers by Tessa Kerre Breakdown of academic impact, for papers by Renate de Boer Breakdown of academic impact, for papers by Henri Vié Breakdown of academic impact, for papers by Michelle A. Hurchla Breakdown of academic impact, for papers by Armin Ghobadi Breakdown of academic impact, for papers by Béatrice Clemenceau
Rankless by CCL
2026